跳至主要内容
临床试验/NL-OMON38189
NL-OMON38189撤回3 期

Effects of glutamine and epigallocatechin-3-gallate on glucose tolerance, markers of inflammation, oxidative stress and procoagulant status in Type 2 diabetes mellitus - Glutamine and EGCG in type 2 diabetes mellitus

Medisch Centrum Alkmaar0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with newly diagnosed type 2 diabetes mellitus
  • Ages eligible for study 30 - 80 years old
  • Genders eligible for study both gender
  • postabsorptive glucose two times >7 mmoll/L,
  • BMI <35kg/M2

排除标准

  • Post absorptive glucose * 15mmol/l
  • Post absorptive glucose * 10 mmol/l and hyperglycemic complaints (polydipsia, polyuria and
  • loss of weight more than 10% in the last month)
  • Creatinine clearance of < 30ml/min.
  • Liver tests (ALAT,ASAT) > 3 times the upper level of normal
  • Patients known to suffer from any malignancy, an acute illness, life threatening disease, or chronic inflammatory condition at the start of the study.
  • Use of corticosteroids or other anti-inflammatory medication
  • Preexisting cardiovascular diseases or atherosclerotic diseases.
  • Pregnancy/breast feeding

研究者

发起方
Medisch Centrum Alkmaar

相似试验

Effects of glutamine and epigallocatechin-3-gallate... | 临床试验